MeVis Medical Solutions AG (M3V) - Total Assets

Latest as of September 2025: €25.89 Million EUR ≈ $30.26 Million USD

Based on the latest financial reports, MeVis Medical Solutions AG (M3V) holds total assets worth €25.89 Million EUR (≈ $30.26 Million USD) as of September 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. See shareholders equity of MeVis Medical Solutions AG for net asset value and shareholders' equity analysis.

MeVis Medical Solutions AG - Total Assets Trend (2006–2025)

This chart illustrates how MeVis Medical Solutions AG's total assets have evolved over time, based on quarterly financial data.

MeVis Medical Solutions AG - Asset Composition Analysis

Current Asset Composition (September 2025)

MeVis Medical Solutions AG's total assets of €25.89 Million consist of 35.0% current assets and 65.0% non-current assets.

Asset Category Amount (EUR) % of Total Assets
Cash & Equivalents €0.00 25.2%
Accounts Receivable €2.28 Million 8.8%
Inventory €0.00 0.0%
Property, Plant & Equipment €308.77K 1.2%
Intangible Assets €0.00 0.0%
Goodwill €0.00 0.0%

Asset Composition Trend (2006–2025)

This chart illustrates how MeVis Medical Solutions AG's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see MeVis Medical Solutions AG market cap and net worth.

Key Asset Composition Facts

  • Current vs. Non-Current Assets: MeVis Medical Solutions AG's current assets represent 35.0% of total assets in 2025, a decrease from 86.3% in 2006.
  • Cash Position: Cash and equivalents constituted 25.2% of total assets in 2025, down from 59.6% in 2006.
  • Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, a decrease from 4.0% in 2006.
  • Asset Diversification: The largest asset category is accounts receivable at 8.8% of total assets.

MeVis Medical Solutions AG Competitors by Total Assets

Key competitors of MeVis Medical Solutions AG based on total assets are shown below.

Company Country Total Assets
Alcidion Group Ltd
AU:ALC
Australia AU$115.63 Million
DocCheck AG
XETRA:AJ91
Germany €53.98 Million
TRELLUS HEALTH LS -0006
F:85Q
Germany €9.22 Million
Pro Medicus Ltd
AU:PME
Australia AU$533.91 Million
Echoiq Ltd
AU:EIQ
Australia AU$17.99 Million
ARTRYA Ltd
AU:AYA
Australia AU$23.68 Million
Cogstate Ltd
AU:CGS
Australia AU$64.77 Million
Oneview Healthcare Plc
AU:ONE
Australia AU$15.49 Million

MeVis Medical Solutions AG - Liquidity and Working Capital Analysis

Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.

Key Liquidity Metrics

Metric Current 1 Year Ago 5 Years Ago
Current Ratio 1.58 1.50 1.48
Quick Ratio 1.58 1.50 1.48
Cash Ratio 0.00 0.00 0.00
Working Capital €3.33 Million €3.19 Million €3.58 Million

MeVis Medical Solutions AG - Advanced Valuation Insights

This section examines the relationship between MeVis Medical Solutions AG's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.

Key Valuation Metrics

Current Price-to-Book Ratio 2.53
Latest Market Cap to Assets Ratio 1.74
Asset Growth Rate (YoY) -2.3%
Total Assets €25.89 Million
Market Capitalization $45.14 Million USD

Valuation Analysis

Above Book Valuation: The market values MeVis Medical Solutions AG's assets above their book value (1.74x), reflecting positive investor sentiment about the company's future prospects.

Slight Asset Contraction: MeVis Medical Solutions AG's assets decreased by 2.3% over the past year, which may reflect streamlining or optimization of resources.

Annual Total Assets for MeVis Medical Solutions AG (2006–2025)

The table below shows the annual total assets of MeVis Medical Solutions AG from 2006 to 2025.

Year Total Assets Change
2025-09-30 €25.89 Million
≈ $30.26 Million
-2.26%
2024-09-30 €26.48 Million
≈ $30.96 Million
-5.60%
2023-09-30 €28.05 Million
≈ $32.80 Million
-10.09%
2022-09-30 €31.20 Million
≈ $36.48 Million
+13.32%
2021-09-30 €27.53 Million
≈ $32.19 Million
-0.93%
2020-09-30 €27.79 Million
≈ $32.49 Million
+16.18%
2019-09-30 €23.92 Million
≈ $27.96 Million
-37.74%
2018-09-30 €38.42 Million
≈ $44.92 Million
-21.72%
2017-09-30 €49.08 Million
≈ $57.38 Million
+14.13%
2016-09-30 €43.00 Million
≈ $50.28 Million
-5.59%
2015-09-30 €45.55 Million
≈ $53.25 Million
+19.07%
2014-09-30 €38.25 Million
≈ $44.72 Million
+11.29%
2013-09-30 €34.37 Million
≈ $40.19 Million
+11.19%
2012-09-30 €30.91 Million
≈ $36.14 Million
-5.02%
2011-09-30 €32.55 Million
≈ $38.05 Million
-16.08%
2010-09-30 €38.78 Million
≈ $45.34 Million
-23.88%
2009-09-30 €50.95 Million
≈ $59.57 Million
-14.48%
2008-09-30 €59.58 Million
≈ $69.66 Million
+67.49%
2007-09-30 €35.58 Million
≈ $41.59 Million
+290.81%
2006-09-30 €9.10 Million
≈ $10.64 Million
--

About MeVis Medical Solutions AG

XETRA:M3V Germany Health Information Services
Market Cap
$49.79 Million
€42.59 Million EUR
Market Cap Rank
#22272 Global
#1963 in Germany
Share Price
€23.40
Change (1 day)
+0.00%
52-Week Range
€22.20 - €26.40
All Time High
€35.79
About

MeVis Medical Solutions AG develops software for recording, analyzing, and evaluating image data to manufacturers of medical devices, providers of medical IT platforms, and clinical end customers in the United States and Europe. The company provides image-based early detection and diagnosis of epidemiologically important diseases, such as breast, lung, liver, and neurological diseases. It also of… Read more